Tofacitinib Tablets 5 mg, 10 mg Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 5 mg, 10 mg
Reference Brands: Xeljanz(US & EU)
Category: Arthritis
Tofacitinib inhibits Janus kinase (JAK) enzymes, blocking cytokine signaling involved in inflammation. It effectively reduces symptoms and disease progression in rheumatoid arthritis. Benefits include rapid symptom relief, improved joint function, and enhanced quality of life, with an oral formulation providing convenient administration for long-term autoimmune disease management.
Product Description: Tofacitinib tablets are approved in the EU and US for rheumatoid arthritis and other autoimmune diseases. In the EU, Pfizer’s Xeljanz is regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing quality. In the US, FDA approval is based on comprehensive clinical data and biosimilarity assessments. Both regions require detailed dossiers for initial approval and ongoing pharmacovigilance. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support efficient market access for tofacitinib tablets, ensuring adherence to European and American standards for safe, effective treatment of autoimmune conditions, helping you navigate complex regulatory landscapes seamlessly.
Tofacitinib Tablets — third party manufacturing & bulk supply
Tofacitinib Tablets 5 mg, 10 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Indicative minimum order quantity
Tofacitinib Tablets is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Tofacitinib Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Tofacitinib Tablets →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Pegloticase Injecatble
Strength:
8 mg/1.2 mL vial
Form: Injectable (IV solution)
Reference Brands: Krystexxa (US)
View Details
Febuxostat Tablets
Strength:
40 mg, 80 mg
Form: Oral Tablets
Reference Brands: Uloric(EU & US)
View Details
Allopurinol Tablets
Strength:
100 mg, 300 mg
Form: Oral Tablets
Reference Brands: Aloprim(US & EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
